Bhutan vs Kiribati: The number of people with susceptibility test result for rifampicin
Bhutan
96.77
in 2021
Kiribati
96.72
in 2021
Bhutan rank
40th
Kiribati rank
41st
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Kiribati
How they compare
Bhutan currently reports 96.77 against 96.72 in Kiribati, a difference of 0.05.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bhutan ahead.
Bhutan ranks 40th and Kiribati ranks 41st of 146 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.89 | 66.85 | 27.04 | Bhutan |
| 2020s | 98.38 | 93.91 | 4.47 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Kiribati?
- Bhutan, at 96.77 against 96.72 in Kiribati as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Kiribati?
- 0.05, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Kiribati?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Kiribati rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 40th and Kiribati ranks 41st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.